1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic data, comorbidities, and clinical scores of subjects
Characteristic HC (n = 21) MCI (n = 20) AD (n = 19) P Value MCI versus HC AD versus HC AD versus MCI Sex (male/female) 11:10 11:9 11:8 .87 .77 .88 Age (mean ± SD) (yr) 64.57 ± 5.74 66.75 ± 4.08 66.68 ± 5.31 .37 .66 1.00 H/o hypertension 5/21 7/20 9/19 .33 .11 .32 H/o diabetes mellitus 5/21 8/20 10/19 .22 .06 .32 RAVLT cumulative learning score (mean) 48.52 ± 8.46 33.47 ± 10.07 25.21 ± 7.15 <.001 <.001 .035 RAVLT 20-min recall score (mean) 10.00 ± 2.82 5.41 ± 3.74 1.36 ± 1.73 <.001 <.001 .001 ACE-M 93.38 ± 4.11 81.12 ± 11.09 72.00 ± 11.09 <.001 <.001 .020
Note:—H/o indicates History of; RAVLT, Rey auditory verbal learning test; ACE-M, Addenbrooke's Cognitive examination. Significant P values are highlighted in bold.